vs
因塞特（INCY）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是因塞特的1.6倍（$2.1B vs $1.3B），因塞特净利率更高（23.8% vs 15.8%，领先8.0%），因塞特同比增速更快（20.9% vs 11.3%），过去两年Roper Technologies的营收复合增速更高（10.5% vs 10.4%）
因塞特是总部位于美国特拉华州威尔明顿的跨国制药企业，目前在北美、欧洲及亚洲多地设有生产基地与研发中心，专注于创新药物的研发、生产及商业化，为全球患者提供优质的治疗选择。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
INCY vs ROP — 直观对比
营收规模更大
ROP
是对方的1.6倍
$1.3B
营收增速更快
INCY
高出9.6%
11.3%
净利率更高
INCY
高出8.0%
15.8%
两年增速更快
ROP
近两年复合增速
10.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $2.1B |
| 净利润 | $303.3M | $331.0M |
| 毛利率 | — | 69.4% |
| 营业利润率 | 23.7% | 27.2% |
| 净利率 | 23.8% | 15.8% |
| 营收同比 | 20.9% | 11.3% |
| 净利润同比 | 91.7% | 53.7% |
| 每股收益（稀释后） | $1.47 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INCYROP
| Q1 26 | $1.3B | $2.1B | ||
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.4B | $2.0B | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.1B | $1.9B | ||
| Q4 24 | $1.2B | $1.9B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.0B | $1.7B |
净利润INCYROP
| Q1 26 | $303.3M | $331.0M | ||
| Q4 25 | $299.3M | $428.4M | ||
| Q3 25 | $424.2M | $398.5M | ||
| Q2 25 | $405.0M | $378.3M | ||
| Q1 25 | $158.2M | $331.1M | ||
| Q4 24 | $201.2M | $462.3M | ||
| Q3 24 | $106.5M | $367.9M | ||
| Q2 24 | $-444.6M | $337.1M |
毛利率INCYROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 92.0% | 69.5% | ||
| Q3 25 | 92.8% | 69.5% | ||
| Q2 25 | 93.5% | 69.2% | ||
| Q1 25 | 93.0% | 68.7% | ||
| Q4 24 | 92.5% | 68.3% | ||
| Q3 24 | 92.4% | 69.2% | ||
| Q2 24 | 92.7% | 69.5% |
营业利润率INCYROP
| Q1 26 | 23.7% | 27.2% | ||
| Q4 25 | 22.3% | 28.6% | ||
| Q3 25 | 32.5% | 28.4% | ||
| Q2 25 | 43.6% | 28.2% | ||
| Q1 25 | 19.5% | 27.9% | ||
| Q4 24 | 25.6% | 28.0% | ||
| Q3 24 | 12.8% | 28.1% | ||
| Q2 24 | -45.8% | 28.8% |
净利率INCYROP
| Q1 26 | 23.8% | 15.8% | ||
| Q4 25 | 19.9% | 20.8% | ||
| Q3 25 | 31.1% | 19.8% | ||
| Q2 25 | 33.3% | 19.5% | ||
| Q1 25 | 15.0% | 17.6% | ||
| Q4 24 | 17.1% | 24.6% | ||
| Q3 24 | 9.4% | 20.8% | ||
| Q2 24 | -42.6% | 19.6% |
每股收益（稀释后）INCYROP
| Q1 26 | $1.47 | $4.87 | ||
| Q4 25 | $1.46 | $3.97 | ||
| Q3 25 | $2.11 | $3.68 | ||
| Q2 25 | $2.04 | $3.49 | ||
| Q1 25 | $0.80 | $3.06 | ||
| Q4 24 | $0.90 | $4.29 | ||
| Q3 24 | $0.54 | $3.40 | ||
| Q2 24 | $-2.04 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $5.6B | $18.8B |
| 总资产 | $7.3B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资INCYROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $3.1B | $297.4M | ||
| Q3 25 | $2.5B | $320.0M | ||
| Q2 25 | $2.0B | $242.4M | ||
| Q1 25 | $1.9B | $372.8M | ||
| Q4 24 | $1.7B | $188.2M | ||
| Q3 24 | $1.3B | $269.6M | ||
| Q2 24 | $987.3M | $251.5M |
总债务INCYROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益INCYROP
| Q1 26 | $5.6B | $18.8B | ||
| Q4 25 | $5.2B | $19.9B | ||
| Q3 25 | $4.7B | $20.0B | ||
| Q2 25 | $4.2B | $19.6B | ||
| Q1 25 | $3.7B | $19.2B | ||
| Q4 24 | $3.4B | $18.9B | ||
| Q3 24 | $3.2B | $18.5B | ||
| Q2 24 | $3.0B | $18.1B |
总资产INCYROP
| Q1 26 | $7.3B | $34.6B | ||
| Q4 25 | $7.0B | $34.6B | ||
| Q3 25 | $6.3B | $34.6B | ||
| Q2 25 | $5.8B | $33.2B | ||
| Q1 25 | $5.7B | $31.4B | ||
| Q4 24 | $5.4B | $31.3B | ||
| Q3 24 | $5.0B | $31.6B | ||
| Q2 24 | $4.7B | $29.8B |
负债/权益比INCYROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流INCYROP
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $738.0M | ||
| Q3 25 | $559.4M | $869.5M | ||
| Q2 25 | $44.7M | $404.1M | ||
| Q1 25 | $266.1M | $528.7M | ||
| Q4 24 | $381.2M | $722.2M | ||
| Q3 24 | $310.9M | $755.4M | ||
| Q2 24 | $-575.6M | $384.1M |
自由现金流INCYROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率INCYROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度INCYROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率INCYROP
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 1.72× | ||
| Q3 25 | 1.32× | 2.18× | ||
| Q2 25 | 0.11× | 1.07× | ||
| Q1 25 | 1.68× | 1.60× | ||
| Q4 24 | 1.89× | 1.56× | ||
| Q3 24 | 2.92× | 2.05× | ||
| Q2 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
